Bexarotene太阳成集团

作者: 历史  发布:2019-04-13

 

NCT01782742

 

Ligand Pharmaceuticals-National Cancer Institute (NCI)

 

April 2004


August 2001

·In November 2012 we are furthermore planning an international workshop Shakin’ them off? Interdisciplinary perspectives on Minoan Earthquakes, convened by Simon Jusseret (Université Catholique de Louvain, Belgium) and Manuel Sintubin (Katholieke Universiteit Leuven, Belgium), which will take place in Leuven (Belgium).

Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

 

September 2001

 

NCT00055991

欢迎有对于地震考古研究和喇家遗址史前地震感兴趣的年轻朋友及时与我们联系

ReXceptor, Inc.

De wetenschap van de Aarde. Over een levende planeet

NCT00178841

PUBLICATIONS

NCT01504490

 

Phase 1

 

NCT00316030

·At the 2012 Annual Meeting of the Seismological Society of America (17-19 April, 2012, San Diego, California): Earthquakes and Tsunamis at Caostal Archaeological Sites. You find details in the following announcement (pdf ). Abstract submission deadline is 11 January 2012.

Phase 1

·At the EGU meeting (20-24 April 2012, Vienna, Austria) Matthieu Ferry (Géosciences Montpellier, France) and Kris Vanneste (ROB, Belgium) convene a session on Earthquake Geology. Abstract submission deadline is 17 January 2012.

Phase 2

MEETINGS

NCT00306969

International Geoscience Programme
IGCP 567 Earthquake Archaeology

NCT01578499

 

Phase 1-Phase 2

IGCP567地震考古研究项目最新动态消息

NCT01116622

For both conferences IGCP567 will most probably (depending on our funding) be able to offer travel grants.

Phase 3

 

Dartmouth-Hitchcock Medical Center-Genentech, Inc.-Ligand Pharmaceuticals

·The 3rd Workshop on Paleoseismology and Archaeoseismology will be held in Morelia, Mexico from 1 to 8 November 2012. More information will follow soon on the http://www.acambay1912.org.

NCT00125372

 

NCT00003752

 

November 2008

·At the 34th International Geological Congress (IGC), from 2 to 10 August 2012 at Brisbane, Queensland, Australia a special session is convened by Patrick Nunn (Australia), Bruce McFadgen (New Zealand), Iain Stewart (U.K.) and Manuel Sintubin (Belgium) on Natural Hazards and Ancient Societies. Abstract submission deadline is 17 February 2012.

NCT01116622

Following our 2nd INQUA-IGCP567 International Workshop on Active Tectonics, Earthquake Geology, Archaeology and Engineering, held from 18 to 24 September 2011 in Corinth, Greece, Andreas Vött (University of Mainz, Germany) is preparing a special volume on in the Zeitschrift für Geomorphologie. This is a peer-review ISI-indexed journal and hosted up to now three special volumes on tsunamis. If you are interested to contribute to this volume, please contact Andreas Vött (voett@uni-mainz.de).

NCT00425477

 

NCT01007448

Disclaimer: http://www.kuleuven.be/cwis/email_disclaimer.htm

Sarcoma, Kaposi-HIV Infections

· On 22 February 2012 IGCP will celebrate its 40th Anniversary at the UNESCO Headquarters in Paris. Two of our co-leaders will actively participate at this meeting. Iain Stewart (University of Plymouth, U.K.) will focus on the importance of Geosciences for Society and moderate a debate on the prospective vision for the future of IGCP. Manuel Sintubin (Katholieke Universiteit Leuven, Belgium) will reflect on the role of IGCP in geohazard mitigation based on the success of IGCP567.

Phase 2

Georgetown University-Daiichi Sankyo Inc.

April 2001

Solid Tumors-Lymphoma-Multiple Myeloma

Memorial Sloan Kettering Cancer Center-National Cancer Institute (NCI)-Tibotec Pharmaceutical Limited-M.D. Anderson Cancer Center-New York University School of Medicine-Hackensack University Medical Center-Roswell Park Cancer Institute

Merck Sharp & Dohme Corp.

Georgetown University-Daiichi Sankyo Inc.

Valeant Pharmaceuticals International, Inc.

May 2010

NCT00050960

Millennium Pharmaceuticals, Inc.-Seattle Genetics, Inc.-Takeda

January 2008

Leukemia-Myelodysplastic Syndromes-Myelodysplastic/Myeloproliferative Diseases

NCT00125359

NCT00845351

Breast Cancer

Washington University School of Medicine

The Cleveland Clinic

Stanford University-Ligand Pharmaceuticals-AstraZeneca

Dartmouth-Hitchcock Medical Center-Bristol-Myers Squibb-Ligand Pharmaceuticals

October 2001

太阳成集团,December 2005

Bexarotene (Targretin) is a selective RXR agonist approved for the treatment of CTCL.IC50 value:Target: retinoid X receptorExposure of NSCLC cell lines to bexarotene as a single agent had modest growth inhibitory effects (at > 1 μM). However, exposure of several NSCLC lines to bexarotene (1–3 μM) produced significant decreases in the expression of EGFR, Her-2 and TGF mRNA and protein. EGF levels were also decreased to a much lesser degree.

Phase 1

Phase 2

Phase 1

NCT00238628

Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

European Organisation for Research and Treatment of Cancer - EORTC

November 2008

NCT00615784

Cushing's Disease

NCT01782742

Non-small Cell Lung Cancer

Dartmouth-Hitchcock Medical Center-Bristol-Myers Squibb-Ligand Pharmaceuticals

March 2008

Carcinoma, Non-small-cell Lung

Phase 2

Phase 3

Phase 1

February 2001

Solid Tumors-Lymphoma-Multiple Myeloma

November 2006

University of Virginia

Phase 2

AML-Acute Myeloid Leukemia

Lung Cancer

Cutaneous T-cell Lymphoma-Mycosis Fungoides-Sezary Syndrome-Primary Cutaneous Anaplastic Large Cell Lymphoma

April 2003

April 2003

Millennix-National Cancer Institute (NCI)

Phase 1-Phase 2

Alzheimer's Disease

Memorial Sloan Kettering Cancer Center-National Cancer Institute (NCI)

Phase 1-Phase 2

Phase 2

Lymphoma

September 2001

January 2008

December 2009

Phase 3

Beersheva Mental Health Center-Stanley Medical Research Institute

NCT01001143

University of Medicine and Dentistry of New Jersey-Ligand Pharmaceuticals-Rutgers, The State University of New Jersey

Dartmouth-Hitchcock Medical Center-Ligand Pharmaceuticals-Genentech, Inc.

Phase 2

NCT00125359

Dartmouth-Hitchcock Medical Center-Genentech, Inc.-Ligand Pharmaceuticals

Lymphoma

Primary Cutaneous Anaplastic Large Cell Lymphoma-Mycosis Fungoides-Cutaneous T-Cell Lymphoma

Cutaneous T-Cell Lymphoma

Non-small Cell Lung Cancer

Acute Myeloid Leukemia

NCT00534898

January 2007

Raghu Nandan, M.D., Inc-National Cancer Institute (NCI)

Valeant Pharmaceuticals International, Inc.

NCT02061878

University of Virginia

December 2011

Eisai Inc.

November 2008

Dartmouth-Hitchcock Medical Center-Ligand Pharmaceuticals-Genentech, Inc.

Dartmouth-Hitchcock Medical Center-Ligand Pharmaceuticals-Genentech, Inc.

Lymphoma

Parapsoriasis

Phase 2

Abramson Cancer Center of the University of Pennsylvania

Carcinoma, Non-small-cell Lung

Cushing's Disease

Phase 2

December 2005

May 2002

Phase 3

M.D. Anderson Cancer Center-United States Department of Defense

NCT00125372

本文由太阳成集团发布于历史,转载请注明出处:Bexarotene太阳成集团

关键词:

上一篇:太阳成集团考古学与当代科技
下一篇:没有了